Clarification sought from Sun Pharmaceutical Industries

14 May 2015 Evaluate

The Exchange has sought clarification from Sun Pharmaceutical Industries with respect to news article appearing in Business Standard on May 14, 2015 titled ‘Ranbaxy accused of gaming FDA rules to thwart rivals’ which inter-alia states, ‘The lawsuit also names Sun Pharmaceuticals Industries Ltd, which completed its acquisition of Ranbaxy this year’.

The above information is a part of company’s filings submitted to BSE.

 

Sun Pharma Inds. Share Price

1776.20 -19.10 (-1.06%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×